Last reviewed · How we verify
Veradex-E (LANOLIN)
At a glance
| Generic name | LANOLIN |
|---|---|
| Sponsor | ABBE Laboratories, Inc. |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- minor burns
- dry skin
- chapped skin
- fissured skin
- macerated skin
- Psoriasis
- Eczema
- mild sunburn
- abrasions
- diaper dermatitis
Common side effects
Key clinical trials
- Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer (PHASE1)
- Investigating the Impact of Vitamin D Biofortified Tomatoes on Serum Levels of 25(OH)D (NA)
- StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients (NA)
- Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation Mastitis (PHASE1)
- Wound Healing After Endoscopic Sinus Surgery (NA)
- Breast Massage and Hot Compress Application to Mothers With Premature Babies at Newborn Intensive Care University Effect on Milk Release and Anxiety (NA)
- Effect of Lanolin and Breastmilk in the Treatment of Sore and Damaged Nipples in Breastfeeding Women (PHASE2)
- Effects of Bend Beauty's Anti-Aging Formula on Inflammatory Markers (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Veradex-E CI brief — competitive landscape report
- Veradex-E updates RSS · CI watch RSS
- ABBE Laboratories, Inc. portfolio CI